Dr Reddys Laboratories Cash Flow Statement (2012-2026) | RDY

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
134.00M93.00M11.00M146.00M134.00M152.00116.83M169.00M170.00M179.04M202.84M144.66M173.33M140.23M166.26M183.30M142.86M133.59M24.12M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)
1.21M1.28M1.31M1.15M
Deferred Taxes (Quarter)
Cash from Discontinued Operations (Quarter)
-46.76M68.91M231.31M86.30M116.41M283.31M136.93M216.85M120.34M101.85M170.94M
Gains from Investment Securities (Quarter)
-10.68M-16.17M-8.53M-6.27M
Asset Writedowns and Impairment (Quarter)
11.00M1.00M95.00M2.007.00M1.00M0.67M1.32M-2.08M0.06M11.03M-0.05M8.87M19.10M-11.16M3.04M28.29M
Non-cash Items (Quarter)
70.14M472.72M258.08M846.54M455.60M788.48M120.20M317.18M767.03M208.19M447.66M768.82M
Change in Working Capital (Quarter)
Change in Inventory (Quarter)
670.76M676.71M615.12M592.06M437.14M765.26M-75.80M-59.79M820.89M-71.86M869.27M837.18M
Change in Accured Expenses (Quarter)
Other Working Capital Changes (Quarter)
-102.03M-11.50M-40.16M-3.22M
Cash from Operations (Quarter)
101.85M111.23M170.94M178.54M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Amortization (Quarter)
440.38M362.35M398.31M375.27M286.75M444.95M1,099.85M1,117.88M1,157.27M1,149.26M
Depreciation & Amortization (CF) (Quarter)
Investing Activities
Capital Expenditures (Quarter)
-61.26M-89.98M-80.17M-59.88M
Sales of Property, Plant and Equipment (Quarter)
2.40M2.52M0.37M1.26M
Change in Intangibles (Quarter)
-15.75M-4.45M-38.40M-56.31M
Acquisitions (Quarter)
Divestments (Quarter)
-76.04M53.57M-36.85M-63.84M71.91M-321.67M-100.25M-54.64M-154.29M313.63M-242.73M-224.25M
Change in Acquisitions & Divestments (Quarter)
566.61M1,381.65M487.71M591.01M
Cash from Investing Activities (Quarter)
-242.73M-227.70M-224.25M-109.41M
Financing Activities
Other financing activities (Quarter)
30.66M-97.33M-34.27M21.65M-140.06M-154.85M7.10M20.10M-17.97M-85.11M-168.75M18.16M114.37M17.87M18.96M-14.06M18.77M18.42M
Cash from Financing Activities (Quarter)
114.37M192.82M-14.06M-61.03M
Additional items
Exchange Rate Effect (Quarter)
0.20M-0.27M2.07M2.24M
Change in Cash (Quarter)
-92.14M25.14M160.19M-103.36M-117.60M33.46M-31.27M-4.77M18.72M77.09M-202.70M124.68M-26.50M76.35M20.75M15.31M-67.37M8.11M94.25M-41.59M
Free Cash Flow (Quarter)
163.10M201.20M251.10M238.42M
Net Cash Flow (Quarter)
-26.50M76.35M-67.37M8.11M